Biomylz Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.89 Cr
as on 16-11-2024
- Revenue 42.86%
(FY 2023)
- Profit -51.94%
(FY 2023)
- Ebitda -50.06%
(FY 2023)
- Net Worth 12.14%
(FY 2023)
- Total Assets 47.90%
(FY 2023)
About Biomylz
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.89 Cr.
Vasanth Samaga, Panathur Padmavathi, Rahul Reddy, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33208KA2017PTC100964
- Company No.
100964
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 2017
- Date of AGM
28 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biomylz Private Limited offer?
Biomylz Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Cosmetics, Hair & Beauty Products, Face Cream, Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots, Cereals & Food Grains, Flours, Essential & Aromatic Oils, Carrier Oil.
Who are the key members and board of directors at Biomylz?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srisailan Krishnamurthy  | Director | 01-Mar-2017 | Current |
| Vasanth Samaga | Director | 18-Jan-2018 | Current |
| Panathur Padmavathi | Director | 01-Mar-2017 | Current |
| Rahul Reddy | Director | 01-Mar-2017 | Current |
| Srinivasa Ragavendra | Director | 18-Jan-2018 | Current |
Financial Performance of Biomylz.
Biomylz Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.86% increase. The company also saw a substantial fall in profitability, with a 51.94% decrease in profit. The company's net worth Soared by an impressive increase of 12.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biomylz?
In 2023, Biomylz had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Nov 2022 | ₹1.16 Cr | Open |
Others Creation Date: 31 Oct 2022 | ₹1.73 Cr | Open |
How Many Employees Work at Biomylz?
Biomylz has a workforce of 56 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biomylz, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomylz's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
